Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devine

Showing results (521-530 of 577) with videos related to

Pageof 58
Sort By:
Critical Care Medicine|March 3, 2026
Executive Summary: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress SyndromeBrian L Erstad, Miguel A Cobas, Nida Qadir, et al.
JAMA|March 7, 2023
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell TransplantLaura W Dillon, Gege Gui, Kristin M Page, et al.
Bone Marrow Transplantation|October 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemiaPranay S Hegde, Georgia Andrew, Gege Gui, et al.
Nature|April 22, 2026
Ubiquitination of glycogen and metabolites in cells and tissuesMarco Jochem, Simon A Cobbold, Craig A Goodman, et al.
Bone Marrow Transplantation|April 10, 2022
Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor AssociationMonique M Jöris, Alexander H Schmidt, Stefanie N Bernas, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Measurable Residual <i>IDH1</i> before Allogeneic Transplant for Acute Myeloid LeukemiaGege Gui, Laura W Dillon, Niveditha Ravindra, et al.
Molecular Biology and Evolution|September 2, 2003
Genome engineering reveals large dispensable regions in Bacillus subtilisHelga Westers, Ronald Dorenbos, Jan Maarten van Dijl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2019
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual DiseaseChristopher S Hourigan, Laura W Dillon, Gege Gui, et al.
Transplantation and Cellular Therapy|March 29, 2021
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical TrialBart L Scott, Marcelo C Pasquini, Mingwei Fei, et al.
JCO Precision Oncology|May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic SyndromeLaura W Dillon, Gege Gui, Brent R Logan, et al.
Pageof 58

Showing results (521-530 of 577) with videos related to

Sort By:
Pageof 58
Critical Care Medicine|March 3, 2026
Executive Summary: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress SyndromeBrian L Erstad, Miguel A Cobas, Nida Qadir, et al.
JAMA|March 7, 2023
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell TransplantLaura W Dillon, Gege Gui, Kristin M Page, et al.
Bone Marrow Transplantation|October 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemiaPranay S Hegde, Georgia Andrew, Gege Gui, et al.
Nature|April 22, 2026
Ubiquitination of glycogen and metabolites in cells and tissuesMarco Jochem, Simon A Cobbold, Craig A Goodman, et al.
Bone Marrow Transplantation|April 10, 2022
Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor AssociationMonique M Jöris, Alexander H Schmidt, Stefanie N Bernas, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Measurable Residual <i>IDH1</i> before Allogeneic Transplant for Acute Myeloid LeukemiaGege Gui, Laura W Dillon, Niveditha Ravindra, et al.
Molecular Biology and Evolution|September 2, 2003
Genome engineering reveals large dispensable regions in Bacillus subtilisHelga Westers, Ronald Dorenbos, Jan Maarten van Dijl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2019
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual DiseaseChristopher S Hourigan, Laura W Dillon, Gege Gui, et al.
Transplantation and Cellular Therapy|March 29, 2021
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical TrialBart L Scott, Marcelo C Pasquini, Mingwei Fei, et al.
JCO Precision Oncology|May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic SyndromeLaura W Dillon, Gege Gui, Brent R Logan, et al.
Pageof 58